Global death counts due to cardiovascular disease (CVD) increased from 12.4 million in 1990 to 19.8 million in 2022, reflecting global population growth and aging and the contributions from ...

Until about 15 years ago, most cardiologists were found in private practices, where the physicians – usually in groups – owned the practice and had privileges for hospital-based services at one or ...

"Who I am NOT has captured a lot of people's attention. So, who am I? I am Cathie Biga, a leader, health care administrator, nurse, executive, mom, wife, nana and I still think of myself as a ...

The U.S. Food and Drug Administration has approved on April 2 the Abbott TriClip™, a transcatheter edge-to-edge repair (TEER) system specifically designed for the treatment of tricuspid regurgitation ...

The 2023 European Society of Hypertension (ESH) and 2017 American College of Cardiology/American Heart Association (ACC/AHA) hypertension guidelines both emphasize proper blood pressure (BP) ...

Digitoxin in addition to guideline-directed medical therapy, reduced the risk of a composite of all-cause death and hospitalization for worsening heart failure (HF) among patients with advanced HF and ...

In this episode, Clyde W. Yancy, MD, MSc, MACC, and Leslie L. Davis, NP, PhD, FACC, discuss the 2022 AHA/ACC/HFSA Guideline for the Management of HF and where to consider newer treatments with ...

Patients with atrial fibrillation (AFib) who drank an average of one cup of coffee a day following successful cardioversion had fewer recurrences of AFib or atrial flutter compared with those who ...

In this episode, Keith C. Ferdinand, MD, FACC, discusses why low blood pressure (BP) should not delay heart failure (HF) treatment.

A new nasal spray form of bumetanide may reduce the tissue swelling caused by heart failure (HF) as effectively as the standard oral and intravenous formulations of the loop diuretic, based on ...

Semaglutide, the popular anti-obesity medication originally developed to treat diabetes, continues to show cardiovascular benefits beyond weight loss, including reducing risk of death, reducing ...

Beta-blocker therapy following myocardial infarction (MI) was the primary focus of a hot line session at ESC Congress 2025. Study investigators presented findings from the REBOOT-CNIC and ...